**Pieris Pharmaceuticals Announces Results of 2024 Annual Meeting and Updates on Merger Agreement**On December 2, 2024, Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS) held its annual meeting of stockholders where significant decisions were made. A quoru
This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read Pieris Pharmaceuticals’s 8K filing here. About Pieris Pharmaceuticals (Get Free Report) Pieris Pharmaceuticals, Inc, a biotechnology company, discovers and develops biotechnological applications. The company focuses on the development of its 4-1BB bispecifics […]
More Stories
France’s Far-Left Protests on Halloween Descend Into Violence as Unrest Spreads Across Europe
By Etienne Fauchaire PARIS—Tens of thousands of left-wing demonstrators marched along the eastern edge of Paris on Saturday, in a...
Judge Dismisses Trump’s Defamation Lawsuit Against Wall Street Journal Publisher
By Tom Gantert A federal judge on Oct. 31 dismissed President Donald Trump’s defamation lawsuit against The Wall Street Journal’s...
Cybersecurity Researchers Link North Korea to $6.4 Billion Binance Hack
By Ryan Morgan Private blockchain analysis companies TRM Labs and Chainalysis have both assessed that North Korean state-backed hackers were...
US Approves Possible $2.1 Billion Sale of 500 Patriot Missiles to Ukraine
By Kimberly Hayek The State Department announced Oct. 30 that it has approved a possible sale of 500 Patriot Advanced...
Who is Timothy Busfield? Cases, Movies, Shows, and Wife
After spending several years under the allegation of child abuse charges, a New Mexico judge has finally issued a judgment....
Economic Momentum Builds as New Figures Beat Expectations
By Andrew Morand and Emel Akan The U.S. economy may be doing more than weathering recent shocks. A fresh batch...